Culagbang, Princess Yen M.

HRN: 21-94-20  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/02/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/02/2023
06/09/2023
IV
80mg
Q8hours
AGE With Moderate Dehydration
Waiting Final Action 
06/03/2023
CEFUROXIME 750MG (VIAL)
06/03/2023
06/09/2023
IV
217mg
Q8
UTI
Waiting Final Action 
06/06/2023
CEFTRIAXONE 1G (VIAL)
06/06/2023
06/12/2023
IV DRIP
520 Mg
Q24
UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: